Literature DB >> 20812042

[Benign prostatic hyperplasia and urolithiasis].

P Krombach1, M S Michel.   

Abstract

Benign prostatic hyperplasia and urolithiasis are widespread diseases and are two of the most important elements of the urological therapeutic spectrum. This article gives an overview of the most interesting publications on the subject from the past few years. Particularly the link with cardiovascular risk factors like obesity and diabetes appears to be stronger than supposed. The diagnostic and therapeutic tools of the future will be developed with respect to this.

Entities:  

Mesh:

Year:  2010        PMID: 20812042     DOI: 10.1007/s00120-010-2379-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

1.  Single-port transvesical enucleation of the prostate: a clinical report of 34 cases.

Authors:  Mihir M Desai; Khaled Fareed; Andre K Berger; Juan Carlos Astigueta; Brian H Irwin; Monish Aron; James Ulchaker; Rene Sotelo
Journal:  BJU Int       Date:  2010-03-15       Impact factor: 5.588

Review 2.  Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Charalampos Mamoulakis; Dirk T Ubbink; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2009-07-07       Impact factor: 20.096

3.  [Treatment of benign prostatic hyperplasia with the Revolix laser].

Authors:  Stefano Mattioli; Rubén Muñoz; Ricard Recasens; Carlos Berbegal; Jordi Cortada; José M Urmeneta; Heinrich Teichmann
Journal:  Arch Esp Urol       Date:  2008-11       Impact factor: 0.436

4.  Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.

Authors:  Giuseppe Brisinda; Federica Cadeddu; Serafino Vanella; Pasquale Mazzeo; Gaia Marniga; Giorgio Maria
Journal:  Urology       Date:  2008-11-08       Impact factor: 2.649

5.  An insidious risk factor for cardiovascular disease: benign prostatic hyperplasia.

Authors:  Omer Faruk Karatas; Omer Bayrak; Ersin Cimentepe; Dogan Unal
Journal:  Int J Cardiol       Date:  2009-04-09       Impact factor: 4.164

Review 6.  Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.

Authors:  J Kellogg Parsons; Aruna V Sarma; Kevin McVary; John T Wei
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

7.  Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

Authors:  Grégoire Robert; Aurélien Descazeaud; Nathalie Nicolaïew; Stéphane Terry; Nanor Sirab; Francis Vacherot; Pascale Maillé; Yves Allory; Alexandre de la Taille
Journal:  Prostate       Date:  2009-12-01       Impact factor: 4.104

8.  Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.

Authors:  Roman Szlauer; Robert Götschl; Aria Razmaria; Ljiljana Paras; Nikolaus T Schmeller
Journal:  Eur Urol       Date:  2008-11-12       Impact factor: 20.096

9.  Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.

Authors:  Abdulla Al-Ansari; Abdulla Al-Naimi; Abdulkader Alobaidy; Khalid Assadiq; Mohamed D Azmi; Ahmed A Shokeir
Journal:  Urology       Date:  2010-01       Impact factor: 2.649

10.  Preperitoneal robotic prostate adenomectomy.

Authors:  Hubert John; Christine Bucher; Nadja Engel; Boris Fischer; Jean-Luc Fehr
Journal:  Urology       Date:  2009-02-04       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.